Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency - Summary of Options Activity (Details)

v3.5.0.2
Stockholders' Deficiency - Summary of Options Activity (Details)
6 Months Ended
Jun. 30, 2016
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of shares options outstanding | shares 7,781,667
Number of shares options granted | shares 130,000
Number of shares options exercised | shares
Number of shares options canceled/forfeited | shares (146,667)
Number of shares options outstanding | shares 7,765,000
Number of shares options exercisable | shares 6,871,000
Weighted average exercise price options outstanding | $ / shares $ 1.15
Weighted average exercise price options granted | $ / shares 0.38
Weighted average exercise price options exercised | $ / shares
Weighted average exercise price options canceled/forfeited | $ / shares 0.75
Weighted average exercise price options outstanding | $ / shares 1.14
Weighted average exercise price option exercisable | $ / shares $ 1.19
Weighted average remaining life in years outstanding 2 years 3 months 18 days
Weighted average remaining life in years exercisable 2 years 2 months 12 days
Aggregate intrinsic value outstanding | $ $ 21,600
Aggregate intrinsic value exercisable | $ $ 21,600